POTESTIO, LUCA
POTESTIO, LUCA
Tildrakizumab for the Treatment of Moderate-to-Severe Psoriasis: Results from 52 Weeks Real-Life Retrospective Study
2023 Ruggiero, Angelo; Fabbrocicni, Gabriella; Cacciapuoti, Sara; Potestio, Luca; Gallo, Lucia; Megna, Matteo
Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection
2023 Potestio, Luca; Piscitelli, Ilaria; Fabbrocini, Gabriella; Martora, Fabrizio; Ruggiero, Angelo; Megna, Matteo
Airborne and systemic allergic contact dermatitis due to corticosteroids
2023 Potestio, Luca; Napolitano, Maddalena; Vico, Francesca Di; Fabbrocini, Gabriella; Patruno, Cataldo
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients
2023 Megna, Matteo; Camela, Elisa; Battista, Teresa; Genco, Lucia; Martora, Fabrizio; Noto, Matteo; Picone, Vincenzo; Ruggiero, Angelo; Monfrecola, Giuseppe; Fabbrocini, Gabriella; Potestio, Luca
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients
2023 Megna, Matteo; Camela, Elisa; Battista, Teresa; Genco, Lucia; Martora, Fabrizio; Noto, Matteo; Picone, Vincenzo; Ruggiero, Angelo; Monfrecola, Giuseppe; Fabbrocini, Gabriella; Potestio, Luca
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience
2023 Martora, Fabrizio; Megna, Matteo; Battista, Teresa; Potestio, Luca; Annunziata, Maria Carmela; Marasca, Claudio; Villani, Alessia; Fabbrocini, Gabriella
Assessment of the efficacy, skin acceptability and cosmetic quality of an adjuvant cream based on 40% urea and amino-inositol in the treatment of mild psoriasis
2022 Megna, Matteo; Potestio, Luca; Genco, Lucia; Noto, Matteo; Fabbrocini, Gabriella
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review
2022 Ruggiero, Angelo; Martora, Fabrizio; Fabbrocini, Gabriella; Villani, Alessia; Marasca, Claudio; Megna, Matteo; Fornaro, Luigi; Comune, Rosita; Potestio, Luca
Cutaneous reactions following COVID-19 vaccination: The evidence says "less fear"
2022 Potestio, Luca; Fabbrocini, Gabriella; D'Agostino, Michela; Piscitelli, Ilaria; Martora, Fabrizio
Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature
2022 Martora, Fabrizio; Battista, Teresa; Marasca, Claudio; Genco, Lucia; Fabbrocini, Gabriella; Potestio, Luca
Letter to the editor regarding article "Hlaca N, Zagar T, Kastelan M, Peternel S, Brajac I, Prpic-Massari L. New-onset lichen planus and lichen planus flare in elderly women after COVID-19 vaccination. J Cosmet Dermatol. 2022;10.1111/jocd.15185"
2022 Potestio, Luca; Villani, Alessia; Fabbrocini, Gabriella; Martora, Fabrizio
Drug safety evaluation of tildrakizumab for psoriasis: a review of the current knowledge
2022 Ruggiero, Angelo; Camela, Elisa; Potestio, Luca; Fabbrocini, Gabriella; Megna, Matteo
Paradoxical reactions to biologicals for psoriasis
2022 Camela, Elisa; Potestio, Luca; Fabbrocini, Gabriella; Megna, Matteo
A case of erythrodermic psoriasis rapidly and successfully treated with Bimekizumab
2022 Megna, Matteo; Battista, Teresa; Potestio, Luca; Ruggiero, Angelo; Ventura, Virginia; Fabbrocini, Gabriella; Picone, Vincenzo
Tildrakizumab for the treatment of moderate to severe psoriasis: results from a single center preliminary real‐life study
2022 Ruggiero, Angelo; Potestio, Luca; Cacciapuoti, Sara; Gallo, Lucia; Battista, Teresa; Camela, Elisa; Fabbrocini, Gabriella; Megna, Matteo
Dupilumab dose spacing after initial successful treatment or adverse events in adult patients with atopic dermatitis: a retrospective analysis
2022 Patruno, Cataldo; Potestio, Luca; Fabbrocini, Gabriella; Napolitano, Maddalena
Reply to "A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine"
2022 Martora, Fabrizio; Fabbrocini, Gabriella; Guerrasio, Gianluca; Potestio, Luca
Reply to 'Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study' by Bawane J et al
2022 Potestio, L; Genco, L; Villani, A; Marasca, C; Fabbrocini, G; Fornaro, L; Ruggiero, A; Martora, F
Reply to “A case of symmetrical drug‐related intertriginous and flexural exanthema‐like eruption associated with Pfizer COVID ‐19 vaccination” by Manaa et al
2022 Camela, Elisa; Scalvenzi, Massimiliano; Megna, Matteo; Potestio, Luca; Guerrasio, Gianluca; Fornaro, Luigi; Fabbrocini, Gabriella; Costa, Claudia
COVID-19 vaccination and inflammatory skin diseases
2022 Martora, Fabrizio; Villani, Alessia; Battista, Teresa; Fabbrocini, Gabriella; Potestio, Luca
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Tildrakizumab for the Treatment of Moderate-to-Severe Psoriasis: Results from 52 Weeks Real-Life Retrospective Study | 1.1 Articolo in rivista | 2023 | Ruggiero, Angelo; Fabbrocicni, Gabriella; Cacciapuoti, Sara; Potestio, Luca; Gallo, Lucia; Megna, Matteo | |
| Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection | 1.1 Articolo in rivista | 2023 | Potestio, Luca; Piscitelli, Ilaria; Fabbrocini, Gabriella; Martora, Fabrizio; Ruggiero, Angelo; Megna, Matteo | |
| Airborne and systemic allergic contact dermatitis due to corticosteroids | 1.1 Articolo in rivista | 2023 | Potestio, Luca; Napolitano, Maddalena; Vico, Francesca Di; Fabbrocini, Gabriella; Patruno, Cataldo | |
| Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients | 1.1 Articolo in rivista | 2023 | Megna, Matteo; Camela, Elisa; Battista, Teresa; Genco, Lucia; Martora, Fabrizio; Noto, Matteo; Picone, Vincenzo; Ruggiero, Angelo; Monfrecola, Giuseppe; Fabbrocini, Gabriella; Potestio, Luca | |
| Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients | 1.1 Articolo in rivista | 2023 | Megna, Matteo; Camela, Elisa; Battista, Teresa; Genco, Lucia; Martora, Fabrizio; Noto, Matteo; Picone, Vincenzo; Ruggiero, Angelo; Monfrecola, Giuseppe; Fabbrocini, Gabriella; Potestio, Luca | |
| Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience | 1.1 Articolo in rivista | 2023 | Martora, Fabrizio; Megna, Matteo; Battista, Teresa; Potestio, Luca; Annunziata, Maria Carmela; Marasca, Claudio; Villani, Alessia; Fabbrocini, Gabriella | |
| Assessment of the efficacy, skin acceptability and cosmetic quality of an adjuvant cream based on 40% urea and amino-inositol in the treatment of mild psoriasis | 1.1 Articolo in rivista | 2022 | Megna, Matteo; Potestio, Luca; Genco, Lucia; Noto, Matteo; Fabbrocini, Gabriella | |
| The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review | 1.1 Articolo in rivista | 2022 | Ruggiero, Angelo; Martora, Fabrizio; Fabbrocini, Gabriella; Villani, Alessia; Marasca, Claudio; Megna, Matteo; Fornaro, Luigi; Comune, Rosita; Potestio, Luca | |
| Cutaneous reactions following COVID-19 vaccination: The evidence says "less fear" | 1.1 Articolo in rivista | 2022 | Potestio, Luca; Fabbrocini, Gabriella; D'Agostino, Michela; Piscitelli, Ilaria; Martora, Fabrizio | |
| Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature | 1.1 Articolo in rivista | 2022 | Martora, Fabrizio; Battista, Teresa; Marasca, Claudio; Genco, Lucia; Fabbrocini, Gabriella; Potestio, Luca | |
| Letter to the editor regarding article "Hlaca N, Zagar T, Kastelan M, Peternel S, Brajac I, Prpic-Massari L. New-onset lichen planus and lichen planus flare in elderly women after COVID-19 vaccination. J Cosmet Dermatol. 2022;10.1111/jocd.15185" | 1.1 Articolo in rivista | 2022 | Potestio, Luca; Villani, Alessia; Fabbrocini, Gabriella; Martora, Fabrizio | |
| Drug safety evaluation of tildrakizumab for psoriasis: a review of the current knowledge | 1.1 Articolo in rivista | 2022 | Ruggiero, Angelo; Camela, Elisa; Potestio, Luca; Fabbrocini, Gabriella; Megna, Matteo | |
| Paradoxical reactions to biologicals for psoriasis | 1.1 Articolo in rivista | 2022 | Camela, Elisa; Potestio, Luca; Fabbrocini, Gabriella; Megna, Matteo | |
| A case of erythrodermic psoriasis rapidly and successfully treated with Bimekizumab | 1.1 Articolo in rivista | 2022 | Megna, Matteo; Battista, Teresa; Potestio, Luca; Ruggiero, Angelo; Ventura, Virginia; Fabbrocini, Gabriella; Picone, Vincenzo | |
| Tildrakizumab for the treatment of moderate to severe psoriasis: results from a single center preliminary real‐life study | 1.1 Articolo in rivista | 2022 | Ruggiero, Angelo; Potestio, Luca; Cacciapuoti, Sara; Gallo, Lucia; Battista, Teresa; Camela, Elisa; Fabbrocini, Gabriella; Megna, Matteo | |
| Dupilumab dose spacing after initial successful treatment or adverse events in adult patients with atopic dermatitis: a retrospective analysis | 1.1 Articolo in rivista | 2022 | Patruno, Cataldo; Potestio, Luca; Fabbrocini, Gabriella; Napolitano, Maddalena | |
| Reply to "A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine" | 1.7 Commento, erratum, replica e simili | 2022 | Martora, Fabrizio; Fabbrocini, Gabriella; Guerrasio, Gianluca; Potestio, Luca | |
| Reply to 'Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study' by Bawane J et al | 1.7 Commento, erratum, replica e simili | 2022 | Potestio, L; Genco, L; Villani, A; Marasca, C; Fabbrocini, G; Fornaro, L; Ruggiero, A; Martora, F | |
| Reply to “A case of symmetrical drug‐related intertriginous and flexural exanthema‐like eruption associated with Pfizer COVID ‐19 vaccination” by Manaa et al | 1.7 Commento, erratum, replica e simili | 2022 | Camela, Elisa; Scalvenzi, Massimiliano; Megna, Matteo; Potestio, Luca; Guerrasio, Gianluca; Fornaro, Luigi; Fabbrocini, Gabriella; Costa, Claudia | |
| COVID-19 vaccination and inflammatory skin diseases | 1.1 Articolo in rivista | 2022 | Martora, Fabrizio; Villani, Alessia; Battista, Teresa; Fabbrocini, Gabriella; Potestio, Luca |